ACTB
Actin, cytoplasmic 1
Also known as: ACTB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P60709
- Gene
- ACTB
- Ensembl
- ENSG00000075624
- Chromosome
- 7
- Canonical length
- 375 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes one of six different actin proteins. Actins are highly conserved proteins that are involved in cell motility, structure, integrity, and intercellular signaling. The encoded protein is a major constituent of the contractile apparatus and one of the two nonmuscle cytoskeletal actins that are ubiquitously expressed. Mutations in this gene cause Baraitser-Winter syndrome 1, which is characterized by intellectual disability with a distinctive facial appearance in human patients. Numerous pseudogenes of this gene have been identified throughout the human genome. [provided by RefSeq, Aug 2017]
Canonical amino-acid sequenceUniProt
375 residues, UniProt reviewed canonical sequence.
>P60709|ACTB
1 MDDDIAALVV DNGSGMCKAG FAGDDAPRAV FPSIVGRPRH QGVMVGMGQK DSYVGDEAQS
61 KRGILTLKYP IEHGIVTNWD DMEKIWHHTF YNELRVAPEE HPVLLTEAPL NPKANREKMT
121 QIMFETFNTP AMYVAIQAVL SLYASGRTTG IVMDSGDGVT HTVPIYEGYA LPHAILRLDL
181 AGRDLTDYLM KILTERGYSF TTTAEREIVR DIKEKLCYVA LDFEQEMATA ASSSSLEKSY
241 ELPDGQVITI GNERFRCPEA LFQPSFLGME SCGIHETTFN SIMKCDVDIR KDLYANTVLS
301 GGTTMYPGIA DRMQKEITAL APSTMKIKII APPERKYSVW IGGSILASLS TFQQMWISKQ
361 EYDESGPSIV HRKCFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACTB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 8,353 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 8,353 nTPM
- colon: 7,819 nTPM
- smooth muscle: 5,356 nTPM
- endometrium: 5,204 nTPM
- tonsil: 4,310 nTPM
- urinary bladder: 4,144 nTPM
Single-cell type
- megakaryocytes: 22,056 nCPM
- platelets: 18,691 nCPM
- extravillous trophoblasts: 16,962 nCPM
- esophageal apical cells: 15,922 nCPM
- hofbauer cells: 15,052 nCPM
- neutrophils: 11,009 nCPM
Immune cell
- total PBMC: 37,458 nTPM
- eosinophil: 29,722 nTPM
- non-classical monocyte: 22,992 nTPM
- intermediate monocyte: 19,675 nTPM
- myeloid DC: 19,334 nTPM
- classical monocyte: 18,132 nTPM
Brain region
- white matter: 3,695 nTPM
- medulla oblongata: 2,928 nTPM
- thalamus: 2,595 nTPM
- spinal cord: 2,482 nTPM
- pons: 2,383 nTPM
- cerebellum: 2,314 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACTB.
Disease | AllUniProt
Conditions ACTB is implicated in, by any mechanism.
- Dystonia-deafness syndrome 1 (DDS1) MIM:607371
- Baraitser-Winter syndrome 1 (BRWS1) MIM:243310
- Thrombocytopenia 8, with dysmorphic features and developmental delay (THC8) MIM:620475
- Becker nevus syndrome (BNS) MIM:604919
- Congenital smooth muscle hamartoma, with or without hemihypertrophy (CSMH) MIM:620470
Disease | GeneticClinVar
138 pathogenic / likely-pathogenic of 679 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Baraitser-Winter syndrome 1
- Inborn genetic diseases
- ACTB-related disorder
- Developmental malformations-deafness-dystonia syndrome
- ACTB-associated syndromic thrombocytopenia
Disease | ImmuneIEDB
Conditions an epitope on ACTB was assayed in.
- multiple sclerosis B and T cell
- allergic disease T cell
- rheumatoid arthritis B and T cell
- onchocerciasis B cell
- hepatocellular carcinoma T cell
- autoimmune hepatitis B cell
- primary biliary cholangitis B cell
- Sjogren's syndrome B cell
- systemic lupus erythematosus B cell
- type 1 diabetes mellitus B cell
- sarcoidosis T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.23
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 5.02
- DepMap mean gene effect
- -0.63
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adherens junction assembly
- apical protein localization
- axonogenesis
- cell motility
- chromatin remodeling
- cytoskeleton organization
- establishment or maintenance of cell polarity
- maintenance of blood-brain barrier
- morphogenesis of a polarized epithelium
- negative regulation of cell differentiation
- platelet aggregation
- positive regulation of cell differentiation
- positive regulation of cell population proliferation
- positive regulation of DNA-templated transcription
- positive regulation of double-strand break repair
- positive regulation of double-strand break repair via homologous recombination
- positive regulation of myoblast differentiation
- positive regulation of stem cell population maintenance
- positive regulation of T cell differentiation
- protein localization to adherens junction
- regulation of apoptotic process
- regulation of cell cycle
- regulation of double-strand break repair
- regulation of G0 to G1 transition
- regulation of G1/S transition of mitotic cell cycle
- regulation of mitotic metaphase/anaphase transition
- regulation of norepinephrine uptake
- regulation of nucleotide-excision repair
- regulation of protein localization to plasma membrane
- regulation of synaptic vesicle endocytosis
- regulation of transcription by RNA polymerase II
- regulation of transepithelial transport
- substantia nigra development
- cellular response to cytochalasin B
- positive regulation of norepinephrine uptake
Molecular functions
- ATP binding
- ATP hydrolysis activity
- identical protein binding
- kinesin binding
- nitric-oxide synthase binding
- nitric-oxide synthase regulator activity
- protein kinase binding
- structural constituent of cytoskeleton
- structural constituent of postsynaptic actin cytoskeleton
- Tat protein binding
- tau protein binding
- transporter regulator activity
Cellular components
- actin cytoskeleton
- actin filament
- adherens junction
- apical junction complex
- axon
- bBAF complex
- blood microparticle
- brahma complex
- brush border
- calyx of Held
- cell-cell junction
- chromatin
- cortical cytoskeleton
- cytoplasm
- cytoplasmic ribonucleoprotein granule
- cytoskeleton
- cytosol
- dense body
- extracellular exosome
- extracellular space
- focal adhesion
- GBAF complex
- glutamatergic synapse
- kinetochore
- lamellipodium
- membrane
- nBAF complex
- npBAF complex
- NuA4 histone acetyltransferase complex
- nuclear matrix
- nucleoplasm
- nucleosome
- nucleus
- plasma membrane
- postsynaptic actin cytoskeleton
- presynapse
- protein-containing complex
- ribonucleoprotein complex
- RSC-type complex
- Schaffer collateral - CA1 synapse
- SWI/SNF complex
- synapse
- tight junction
- vesicle
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACTB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACTB as an antibody target. Whether an autoantibody or antibody against ACTB could matter depends on whether native ACTB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACTB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACTB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...